Re: Time for the drug companies to move to Galt\'s Gultch
Merck deserved it. Their Cox 2 inhibitors, vioxx, were no better than asprine for those that did not have a cox 2 problem, yet Merck sold it to everyone. It is clear that people accepted an increased risk, with no hope of a superior result, and Merck knew this. I hope Merck goes bust.
Dupont has already stopped work on drugs - to concetrate on their core competency, basic materials.
What you are seeing is a changing of the guard. The future is not bogus non cures like what merck peddles, it is Amgen ect.
|